Company Overview and News

 
Closing Bell: Global cues push Sensex, Nifty higher; midcaps outperform

2018-04-19 moneycontrol
3:30 pm Market Closing: Benchmark indices closed higher despite crude oil prices, backed by metals, technology and FMCG stocks.

 
Market Live: TCS up 1% ahead of Q4 nos, Welspun Corp gains 5% on order win

2018-04-19 moneycontrol
"The state-of-the-art facility enables Honeywell to provide enhanced expertise and training capabilities to customers and expand its production range," the company said.

 
Market Live: Sensex, Nifty continue to trade higher; IndusInd falls 2% post Q4, RIL gains

2018-04-19 moneycontrol
1:52 pm Market Update: The market continued to trade mildly higher, with support from metals, technology and FMCG stocks. It shrugged off higher crude oil prices.

 
Market Live: Nifty holds 10,550 amid consolidation; TCS, HCL, Tech Mahindra rally

2018-04-19 moneycontrol
12:55 pm Buzzing: Allied Digital was locked at 10 percent upper circuit after one-time settlement of its dues to State Bank of India for Rs 60.34 crore.

 
Market Live: Sensex continues to trade higher on global cues; IOC, HPCL, BPCL dip 3-5%

2018-04-19 moneycontrol
774 crore for the construction of third rail line between Jimidipeta and Gotlam on East Coast Railway on engineering, procurement and construction (EPC) basis.

 
Market Live: Sensex trades higher even as Brent crude hits $74/bbl; Metal index up 2%

2018-04-19 moneycontrol
9:59 am Buzzing: Mindtree share price gained 3 percent after the company reported a 28.8 percent sequential growth in profit at Rs 182.2 crore and6.3 percent in revenue at Rs 1,464 crore for the quarter ended March 2018.

 
Market Live: Sensex up 100 pts despite Brent crude hits $74/bbl; Metal index up 2%

2018-04-19 moneycontrol
9:50 am Market Update: The market traded higher despite the sharp upmove in crude oil prices, following positive lead from global peers. Investors closely monitor March quarter earnings to get further market direction.

 
Closing Bell: Nifty rises for 6th straight day, Sensex up 161 pts ahead of macro data

2018-04-12 moneycontrol
3:30 pm Market Closing: Benchmark indices ended higher for the sixth consecutive session, with the Sensex rising 160.69 points to 34,101.13 and the Nifty gaining 41.50 points at 10,458.70 ahead of macro data due later in the day and Infosys earnings tomorrow.

 
Closing Bell: Nifty manages to hold 10,400, Sensex ends higher for 5th day

2018-04-11 moneycontrol
3:30 pm Market Closing: Benchmark indices closed higher for fifth consecutive session on Wednesday. The 30-share BSE Sensex was up 60.19 points at 33,940.44 and the 50-share NSE Nifty rose 14.90 points to 10,417.20.

 
Market Live: Nifty hovers around 10,400; PSU Bank dips 2%, RIL extends gains

2018-04-11 moneycontrol
2:50 pm Europe Lower: Equities in Europe moved lower as investors began to focus on earnings at the start of a new reporting season.

 
Market Update: CNX IT outperforms as TCS, HCL Tech trade higher; SBI, PNB drag PSU bank index lower

2018-04-11 moneycontrol
The Indian equity market was trading on a positive note on Wednesday afternoon with the Nifty adding 17 points at 10,419 mark while the Sensex was up 78 points or 0.23 percent.

 
Market Live: Sensex consolidates ahead of earnings, macro data; IOC, HPCL, BPCL extend loss

2018-04-11 moneycontrol
12:50 pm Market Update: The market continued to consolidate after showing upside in previous four consecutive sessions, as investors look for corporate earnings, macro data and crude oil prices movement.

 
Market Update: Metal stocks shine led by Hindalco, JSPL; Avenue Supermarts hits new 52-week high; PSU banks drag

2018-04-11 moneycontrol
The Indian equity market was still trading on a negative note on Wednesday afternoon with the Nifty shedding 15 points at 10,386 mark while the Sensex was down 11 points.

 
Market Live: Sensex mildly lower amid mixed Asia trade; IT, metals stocks shine

2018-04-11 moneycontrol
11:58 am Acquisition: Narendra Investments (Delhi) informed exchange the completion of acquisition of 51 percent stake in Fudkor India (FUDKOR) and 100 percent stake in Vegico Foods (VEGICO). With this acquisition, both the companies have become 51 percent and 100 percent subsidiaries of Narendra Investments (Delhi), respectively.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...